Among 12 metabolic indices, LCI emerged as the strongest predictor for CP development in this Asian cohort, supporting its use as a simple, noninvasive tool to identify high-risk individuals for subclinical atherosclerosis and improve atherosclerotic cardiovascular disease primary prevention.
He et al. (Fri,) studied this question.